(Q44165271)

30 November 2017

title

Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy (English)

1 reference

30 November 2017

1 reference

1 reference

1 reference

5

Beom S Jeon

1 reference

30 November 2017

Jong-Min Kim

1

1 reference

30 November 2017

Ki Hyeong Lee

series ordinal

2

1 reference

30 November 2017

Yoon-La Choi

series ordinal

3

1 reference

30 November 2017

Gi Yeong Choe

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

17

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

1089-1090

1 reference

Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration

30 November 2017

cites work

1 reference

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers

21 January 2018

1 reference

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

21 January 2018

1 reference

Progressive supranuclear palsy: postmortem chemical analysis

21 January 2018

1 reference

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

21 January 2018

1 reference

A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia

21 January 2018

1 reference

The rationale for the use of dopamine agonists in Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.10246

1 reference

30 November 2017

1 reference